Christine Potkay, Goodwin Procter LLP Associate in the firm's New York office, practices in the firm's Intellectual Property Litigation group

Christine Potkay

Christine Potkay
New York
+1 212 813 8874

Christine Potkay is an associate in Goodwin’s Intellectual Property Litigation practice.

Christine has experience litigating patent and trademark matters in federal court and in proceedings before the United States Patent and Trademark Office and the International Trade Commission (ITC). Christine has represented clients in arbitration proceedings arising from intellectual property licenses and commercial agreements. Christine also maintains an active pro bono practice.


Christine has been involved in various stages of patent litigation, from pre-suit investigation through trial. Some of her engagements include:

  • Representing Dr. Reddy’s Laboratories in litigation concerning its generic equivalent to Suboxone®, a product used to treat opioid use disorder
  • Representing Teva in Hatch-Waxman litigation related to a generic version of a drug product for the treatment of ADHD
  • Represented Civiq Smartscapes, LLC against claims of patent infringement relating to digital outdoor displays
  • Represented Actavis Laboratories in Hatch-Waxman litigation concerning its generic equivalent to Minivelle®, an estradiol transdermal system


Christine maintains an active pro bono practice, including working with the ACLU of Massachusetts and ACLU of Michigan to challenge policies and practices denying medication for the treatment of opioid use disorder (MOUD) to incarcerated people.

Professional Experience

While attending law school, Christine was a judicial intern to the Honorable Jerome B. Simandle, U.S. District Judge for the District of New Jersey (Summer 2015) and the Honorable Michael A. Shipp, U.S. District Judge for the District of New Jersey (Spring 2017).




Rutgers School of Law

(magna cum laude, Order of the Coif)


Rutgers University

(summa cum laude)



  • New York


Christine is an editor of the Goodwin PTAB Trial Tracker periodic newsletter.